Die medizinische und soziale Indikation der Antiandrogen-Behandlung

Publisher Website
Google Scholar
Abstract
The therapy with antiandrogen Cyproteroneacetate (Schering) represents a treatment of libido and sexual potency in men suffering under hypersexuality or deviation of sexual motive power; the method is reversible and always assessable to regulation. Since 2 1/2 years a total of 27 repeatedly prosecuted delinquents have been treated with this orally applied drug. There was no counter-indication related to the age of the men observed. A change of sexual motive powers or any result over and above the medication may not be expected. The best effects are to be expected from old men or younger married persons standing under afflicted power. Character defects or under-standard intelligence oppose long-term, binding measures.

This publication has 0 references indexed in Scilit: